[Image courtesy of Injectech]
Vance Street Medical Molding now includes the Fluid Management Division anchored by Injectech and Resenex and a Contract Manufacturing Division led by PDC, the private equity firm said.
“Positioning Injectech and Resenex together as our Fluid Management Division creates a strong, unified offering for customers,” Vance Street Medical Molding CEO Jeff Kyle said in a news release. “Paired with PDC’s world-class contract manufacturing capabilities, we’re able to deliver a more complete solution, from high-performance fluid-control components to scalable, validated production. This integrated approach gives customers faster development cycles, improved manufacturability, and more confidence in performance for critical fluid management systems.”
Los Angeles-based Vance Street Capital and Fort Collins, Colorado-based Injectech did not disclose terms of their deal.
Founded in 1998, Injectech offers precision injection molding and cleanroom assembly for medical device OEMs, specializing in high-precision, polymer-based fluid management components such as luers, tube-to-tube connectors, check valves, spikes, and custom assemblies.
“Injectech has always focused on solving complex fluid management challenges through precision engineering and responsive manufacturing,” Injectech CEO Jeff Wicks said in the release. “Partnering with Vance Street enables us to expand our technical resources, increase scalability, and continue investing in advanced molding technologies, automation, and material innovation.”
Vance Street Capital Partner Steve Sandbo called Injectech “an exceptional fit within our family of advanced molding and fluid management component manufacturers.”
“Their technical depth, materials expertise, and ability to deliver repeatable performance in mission-critical applications make them a trusted partner to leading OEMs,” he continued. “We look forward to supporting Injectech’s continued investment in process capability and engineering innovation.”
